Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?

BACKGROUND: The Coronavirus (COVID-19), (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) has been spreading worldwide since its first identification in China. It has been speculated that patients with comorbidities and elderly patients could be at high risk for the pandemic reasoned re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gemcioglu, Emin, Davutoglu, Mehmet, Ozdemir, Ese Ece, Erden, Abdulsamet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228888/
https://www.ncbi.nlm.nih.gov/pubmed/32480326
http://dx.doi.org/10.1016/j.msard.2020.102196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228888/
https://www.ncbi.nlm.nih.gov/pubmed/32480326
http://dx.doi.org/10.1016/j.msard.2020.102196

Ejemplares similares